PCNA and neoplasm: Tumor sections from the TRF group showed a decrease in mitotic events (Fig. 2M, N), reductions in the percentages of PCNA-positive nuclei (Fig. 2M, O), and Ki67-positive (Fig. 2M, P) compared to those from the control group, indicating remarkable mitigation of tumor-associated pathological proliferation.